genomics
CRISPR Genomics AMR
Thinking About CRISPR Off-Target Risk in a Clinical Context
How to frame off-target assessment for gene therapy applications — frequency, location, functional consequence, and the questions regulators actually ask.
· 8 min
READ →
NGS INDUCE-seq Genomics
INDUCE-seq: A PCR-Free Window into the Genome's Break Landscape
An overview of INDUCE-seq, how it avoids amplification bias, and why PCR-free DSB detection changes what we can see in the breakome.
· 7 min
READ →